MARKET

WVE

WVE

WAVE LIFE SCIENC
NASDAQ

Real-time Quotes | Nasdaq Last Sale

10.71
+0.68
+6.73%
After Hours: 10.75 +0.05 +0.42% 18:00 03/02 EST
OPEN
10.17
PREV CLOSE
10.03
HIGH
10.74
LOW
9.90
VOLUME
745.00K
TURNOVER
--
52 WEEK HIGH
19.98
52 WEEK LOW
6.61
MARKET CAP
522.17M
P/E (TTM)
-2.1212
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Wave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2020 Financial Results on March 4, 2021
CAMBRIDGE, Mass., Feb 23, 2021 (GLOBE NEWSWIRE via COMTEX) -- CAMBRIDGE, Mass., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a...
GlobeNewswire · 02/23 13:00
Huntington Disease Protein Market Share, Growth, Size, from 2021 to 2026 with Entry Strategies, Countermeasures of Economic Impact and Global Marketing Channels
Feb 22, 2021 (The Expresswire) -- Global Huntington Disease Protein Market 2021 industry research report gives Advancement strategies and plans are talked...
The Express Wire · 02/23 04:49
Will Wave Life Sciences (WVE) Report Negative Q4 Earnings? What You Should Know
Zacks.com · 02/22 22:44
Will Wave Life Sciences (WVE) Report Negative Q4 Earnings? What You Should Know
Zacks.com · 02/22 17:30
Wave Life Sciences to Present at the 10th Annual SVB Leerink Global Healthcare Conference
CAMBRIDGE, Mass., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno...
GlobeNewswire · 02/16 22:00
Huntington Disease Protein Market Size 2021: Covid-19 Impact Analysis by Industry Share, Demand and Supply, Company Profiles, Growth Strategy, Developing Technologies, Opportunities and Forecast by Regions till 2027
The Express Wire · 02/15 05:15
Global Huntington Disease Protein Market Size By Production, Top Countries Import-Export And Consumption Forecast & Regional Analysis By 2026
Feb 10, 2021 (The Expresswire) -- “Global Huntington Disease Protein Market" Forecast 2021-2026 report supports to increase economies with the product...
The Express Wire · 02/10 11:15
Dystrophin Market Share 2021 Product Type, Applications, Industry Size, Revenue, Growth Opportunities, Players, Regions and Forecast to 2026
Feb 10, 2021 (The Expresswire) -- Global “Dystrophin Market” research report delivers significant analysis that benefits business today and will also help to...
The Express Wire · 02/10 09:25
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of WVE. Analyze the recent business situations of WAVE LIFE SCIENC through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average WVE stock price target is 16.57 with a high estimate of 27.00 and a low estimate of 7.00.
EPS
Institutional Holdings
Institutions: 185
Institutional Holdings: 54.19M
% Owned: 111.10%
Shares Outstanding: 48.78M
TypeInstitutionsShares
Increased
35
4.51M
New
46
-1.51M
Decreased
30
4.04M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-2.09%
Pharmaceuticals & Medical Research
-0.90%
Key Executives
Chairman/Independent Director
Christian Henry
President/Chief Executive Officer/Director
Paul Bolno
Chief Financial Officer/Chief Accounting Officer
Kyle Moran
Chief Human Resource Officer
Jonathan Rosin
Senior Vice President
Christopher Francis
Senior Vice President
Kenneth Rhodes
Senior Vice President
Chandra Vargeese
Other
Michael Panzara
Director
Gregory Verdine
Independent Director
Mark Corrigan
Independent Director
Peter Kolchinsky
Independent Director
Koji Miura
Independent Director
Adrian Rawcliffe
Independent Director
Ken Takanashi
Independent Director
Heidi Wagner
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
  • Financials
  • Insiders
More
About WVE
WAVE Life Sciences Ltd. is a genetic medicines company. The Company, through its synthetic chemistry drug development platform, designs, develops and commercializes a pipeline of nucleic acid therapeutic candidates for genetically defined diseases. The Company is engaged in developing oligonucleotides that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. The nucleic acid therapeutics, which the Company is developing are stereopure. A stereopure oligonucleotide includes molecules with atoms arranged in three-dimensional orientations at each linkage. The Company has three programs in Huntington's disease (HD) and Duchenne Muscular Dystrophy (DMD), and three additional development candidates.

Webull offers kinds of Wave Life Sciences Ltd stock information, including NASDAQ:WVE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, WVE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading WVE stock methods without spending real money on the virtual paper trading platform.